Showing results (91-100 of 161) with videos related to
Sort By:
Pageof 17
The Annals of Pharmacotherapy|January 27, 2004
Metabolic bone disease after chronic antacid administration in an infantRenee F Robinson, Marcel J Casavant, Milap C Nahata, et al.Paediatric Drugs|March 22, 2005
Pharmacologic treatment of chronic pediatric hypertensionRenee F Robinson, Milap C Nahata, Donald L Batisky, et al.The Annals of Pharmacotherapy|December 13, 2022
Gaps in Evidence-based Treatment of Concurrent Attention Deficit Hyperactivity Disorder and Opioid Use Disorder: A Scoping ReviewOlivia L Ramey, Andrea E Bonny, Armando Silva Almodóvar, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 9, 2023
Retention in Office-Based Opioid Treatment and Impact on Emergency Department Use in Adolescents and Young Adults With Opioid Use DisorderOlivia L Ramey, Andrea E Bonny, Armando Silva Almodóvar, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2005
Advancing patient care through innovative practice: the Clinical Partners ProgramBella H Mehta, Jennifer L Rodis, Milap C Nahata, et al.Pharmacotherapy|August 19, 2003
Management of nephrotic syndrome in childrenRenee F Robinson, Milap C Nahata, John D Mahan, et al.The Journal of Pediatrics|February 12, 2020
Impact of Office-based Opioid Treatment on Emergency Visits and Hospitalization in Adolescents with Opioid Use DisorderKim S Walker, Andrea E Bonny, Erin R McKnight, et al.Journal of Clinical Pharmacology|July 21, 2006
Population pharmacokinetics of amlodipine in hypertensive children and adolescentsJoseph T Flynn, Milap C Nahata, John D Mahan, et al.Pain|February 1, 1984
Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe painMilap C Nahata, Angela W Miser, James S Miser, et al.The Annals of Pharmacotherapy|February 18, 2011
Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetesJun Wu, Eric Seiber, Veronique A Lacombe, et al.Pageof 17